NCT02230904 - A Study to Compare the Adhesiveness of 2 Different Rotigotine Patches Used for the Treatment of Parkinson's Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

December 31, 2014

Conditions

Parkinson's Disease

Interventions

DRUG

Rotigotine (Test product PR 2.3.1)

"* Pharmaceutical form: Transdermal patch~* Concentration: 8 mg/24 hours~* Route of administration: Transdermal"

DRUG

Rotigotine (Reference product PR 2.1.1)

"* Pharmaceutical form: Transdermal patch~* Concentration: 8 mg/24 hours~* Route of administration: Transdermal"

Trial Locations (11)

104, Alzenau in Unterfranken

106, Aschaffenburg

105, Berlin

107, Böblingen

101, Cologne

111, Düsseldorf

109, Erbach im Odenwald

110, Essen

102, Karlstadt am Main

103, Stuttgart

108, Würzburg